114 related articles for article (PubMed ID: 1708011)
1. First-choice antihypertensive drug use in the Glasgow Blood Pressure Clinic.
Clark DW; Curzio JL; Howie CA; Reid JL
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S120-2. PubMed ID: 1708011
[TBL] [Abstract][Full Text] [Related]
2. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
3. Treating hypertension. Are the right drugs given to the right patients?
Beaulieu MD; Dufresne L; LeBlanc D
Can Fam Physician; 1998 Feb; 44():294-8, 301-2. PubMed ID: 9512833
[TBL] [Abstract][Full Text] [Related]
4. Cost-minimization analysis of initial antihypertensive therapy in patients with mild-to-moderate essential diastolic hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Stading JA; Stoysich AM; Ryschon K
Clin Ther; 1994; 16(1):88-102; discussion 87. PubMed ID: 7911403
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacological hypertension therapy].
Pedersen OL; Christensen KL; Bang LE; Ibsen H; Schultz-Larsen P
Ugeskr Laeger; 2009 Jun; 171(24):2022-5. PubMed ID: 19523367
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological rationale for antihypertensive drug treatment.
Prichard BN
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S6-17. PubMed ID: 2454370
[TBL] [Abstract][Full Text] [Related]
7. [Influence of risk factors and pharmacological treatment on mortality in patients with essential hypertension].
Román O; Cuevas G; Bunout D
Rev Med Chil; 1998 Jul; 126(7):745-52. PubMed ID: 9830766
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
Zanchetti A
J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
[TBL] [Abstract][Full Text] [Related]
9. Antihypertensive drug treatment in a Swedish community: Skaraborg Hypertension and Diabetes Project.
Bøg-Hansen E; Lindblad U; Ranstam J; Melander A; Råstam L
Pharmacoepidemiol Drug Saf; 2002; 11(1):45-54. PubMed ID: 11998551
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drug prescription trends at the primary health care centres in Bahrain.
Jassim al Khaja KA; Sequeira RP; Wahab AW; Mathur VS
Pharmacoepidemiol Drug Saf; 2001 May; 10(3):219-27. PubMed ID: 11501335
[TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension and cardiac decompensation].
Degaute JP
Rev Med Brux; 1996 Sep; 17(4):272-4. PubMed ID: 8927860
[TBL] [Abstract][Full Text] [Related]
12. [[Hypertension treatment of elderly men in Iceland].
Sigurthardóttir V; Einarsson B; Sigfússon N; Hartharson T
Nord Med; 1995; 110(4):119-22. PubMed ID: 7724355
[TBL] [Abstract][Full Text] [Related]
13. Changes in clinical characteristics and drug treatment of hypertension over 40 years at the Dunedin Hypertension Clinic.
Waal-Manning HJ; Paulin JM; Wallis AT; Simpson FO
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S123-5. PubMed ID: 1708012
[TBL] [Abstract][Full Text] [Related]
14. Approach to drug therapy for hypertension.
Kuchel OG; Mahon WA; McKenzie JK; Ogilvie RI
Can Med Assoc J; 1979 Mar; 120(5):565-70. PubMed ID: 35278
[TBL] [Abstract][Full Text] [Related]
15. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
Al Khaja KA; Sequeira RP
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
[TBL] [Abstract][Full Text] [Related]
16. Consumption and costs of antihypertensive drugs in Mexico: are diuretic agents a standing technological trajectory?
Altagracia-Martínez M; Kravzov-Jinich J; Guadarrama-Atrizco MD; Rubio-Poo C; Wertheimer AI
Res Social Adm Pharm; 2006 Mar; 2(1):22-37. PubMed ID: 17138499
[TBL] [Abstract][Full Text] [Related]
17. Response of blood pressure to maximum exercise in hypertensive patients under different therapeutic programs.
de Queiroz Carreira MA; Ribeiro JC; Caldas JA; Tavares LR; Nani E
Arq Bras Cardiol; 2000 Oct; 75(4):281-8. PubMed ID: 11058925
[TBL] [Abstract][Full Text] [Related]
18. Prescribing pattern of antihypertensive drugs in the community.
Rotmensch HH; Mendelevitch L; Silverberg DS; Liron M
J Hum Hypertens; 1996 Sep; 10 Suppl 3():S169-72. PubMed ID: 8872853
[TBL] [Abstract][Full Text] [Related]
19. Current status of antihypertensive prescription and associated blood pressure control in Japan.
Mori H; Ukai H; Yamamoto H; Saitou S; Hirao K; Yamauchi M; Umemura S
Hypertens Res; 2006 Mar; 29(3):143-51. PubMed ID: 16755149
[TBL] [Abstract][Full Text] [Related]
20. Use and adverse reactions of antihypertensive drugs in Spain. Part I of the RAAE Study.
Aranda P; Tamargo J; Aranda FJ; Luque M; López-Garcia-Franco A
Blood Press Suppl; 1997; 1():11-6. PubMed ID: 9285102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
